TMC HealthCare conducts a variety of high-level clinical research trials in an efficient and safe manner in order to improve the well-being and lives for all patients. We are dedicated to taking all the steps necessary to bring quality care through research and giving back to the community for a better health care system. We are committed to honesty; we value our resources; and we implement our values into all the studies we conduct. All research conducted at TMC is dedicated to improving and modernizing the medical industry, providing more efficient and safer treatments worldwide, showing broad and diverse research, and taking a step forward for a better health and future for the community.
Clinical research helps doctors learn new ways to prevent and treat diseases, and find answers to questions about health, disease entity and human behavior. Clinical research leads to the development of new drugs, less-invasive measures of treatment compared with the standard, and new ways to prevent disease in people at high risk. Research also connects our community to leading-edge therapies. Clinical research may include studies for:
Many of our medical advances occurred because people volunteered to participate in clinical trials and other types of clinical research. People choose to participate in clinical research and trials because they want to take part in the advancement of new discoveries, because they feel empowered when they take a more active role in their health, or because they can gain access to new therapies before they are widely available. Volunteers include healthy individuals from surrounding communities as well as people with known health problems.
There are generally four different study types that may be offered at TMC HealthCare:
Clinical research conducted at TMC HealthCare is approved by the Institutional Review Board, or IRB. The IRB is a government-mandated agency that is required by federal law to review and approve all clinical trials involving human subjects. TMC HealthCare strictly follows IRB guidelines to ensure patient safety and health.
What is the Purpose of this Study? To prevent recurrent ischemic stroke with the AMPLATZER PFO occluder device
Principal investigator: Dr. Thomas Waggoner
Link to ClinicalTrials.gov
What is the purpose of this study? To reduce the risk of a peri-procedural stroke after a trancather aortic vale replacement.
Principal investigator: Dr. Thomas Waggoner
Link to ClinicalTrials.gov
What is the purpose of this study? To evaluate the Lotus Edge to treat patients with aortic stenosis.
Principal investigator: Dr. Thomas Waggoner
Link to ClinicalTrials.gov
What is the purpose of this study? To reduce risk of prosthesis-patient mismatch rates in patients with a small annuli.
Principal investigator: Dr. Neil Gheewala
Link to ClinicalTrials.gov
What is the purpose of this study? To provide access to investigational convalescent plasma for patients with high risk of progression to severe COVID-19.
Site lead physicians: Drs. Ives de Chazal and Laura Valdivia
Link to ClinicalTrials.gov
What is the purpose of this study? To evaluate the exposure, immunity, diagnosis, and prognosis of SARS-CoV-2 infections.
Principal investigator: Dr. Katehrine Scott
Link to ClinicalTrials.gov
What is the purpose of this study? To evaluate the if the use of a bidirectional oxygenation mouthpiece with conventional oxygen support enhances respiratory function in any Person Under Investigation for infection by the COVID-19 virus.
Principal investigator: Dr. Matthew Weiner
Link to ClinicalTrials.gov
What is the purpose of this study? To study prevention and early treatment of type 1 diabetes.
Principal investigator: Dr. Chetanbabu Patel
Link to ClinicalTrial.gov
You can also find clinical trials at TMC HealthCare through ClinicalTrials.gov. Use this searchable database of publicly- and privately-supported clinical studies conducted at TMC HealthCare and around the world.
Clinical Research
Office: (520) 324-5512
Email: Research@tmcaz.com